179 related articles for article (PubMed ID: 1388322)
1. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
Lewis BS; Makhoul N; Dakak N; Flugelman MY; Yechiely H; Halon DA; Kahana L
Am Heart J; 1992 Oct; 124(4):1009-16. PubMed ID: 1388322
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide in congestive heart failure: postural changes and reset with chronic captopril therapy.
Rouleau JL; Bichet D; Kortas C
Am Heart J; 1988 May; 115(5):1060-7. PubMed ID: 2966547
[TBL] [Abstract][Full Text] [Related]
3. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
[TBL] [Abstract][Full Text] [Related]
4. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
[TBL] [Abstract][Full Text] [Related]
5. Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy.
Webster MW; Sharpe DN; Coxon R; Murphy J; Hannan S; Nicholls MG; Espiner EA
Am J Cardiol; 1989 Jan; 63(3):217-21. PubMed ID: 2521271
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.
Globits S; Frank H; Pacher B; Huelsmann M; Ogris E; Pacher R
Am Heart J; 1998 Apr; 135(4):592-7. PubMed ID: 9539472
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.
Dakak N; Makhoul N; Merdler A; Yechiely H; Kahana L; Halon DA; Schneeweiss A; Lewis BS
Eur Heart J; 1993 Jun; 14(6):836-44. PubMed ID: 8325314
[TBL] [Abstract][Full Text] [Related]
8. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
Dakak N; Makhoul N; Flugelman MY; Merdler A; Shehadeh H; Schneeweiss A; Halon DA; Lewis BS
Am J Cardiol; 1990 Sep; 66(5):608-13. PubMed ID: 2118301
[TBL] [Abstract][Full Text] [Related]
9. Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
Tsutamoto T; Kinoshita M; Ohbayashi Y; Wada A; Maeda Y; Adachi T
Circulation; 1994 Aug; 90(2):823-9. PubMed ID: 8044954
[TBL] [Abstract][Full Text] [Related]
10. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
11. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
[TBL] [Abstract][Full Text] [Related]
12. Infusion of atrial natriuretic peptide to patients with congestive heart failure.
Goy JJ; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner HR
J Cardiovasc Pharmacol; 1988; 12(5):562-70. PubMed ID: 2468056
[TBL] [Abstract][Full Text] [Related]
13. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
[TBL] [Abstract][Full Text] [Related]
14. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide responses during anaesthesia in patients with refractory cardiomyopathies.
Glisson SN; Gutzke GE; Pifarre R; Rao TL
Can J Anaesth; 1991 Jul; 38(5):572-7. PubMed ID: 1834358
[TBL] [Abstract][Full Text] [Related]
16. M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
McKie PM; Cataliotti A; Ichiki T; Sangaralingham SJ; Chen HH; Burnett JC
J Am Heart Assoc; 2014 Jan; 3(1):e000206. PubMed ID: 24385449
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
[TBL] [Abstract][Full Text] [Related]
18. Captopril does not prevent nitroglycerin tolerance in heart failure.
Dupuis J; Lalonde G; Bichet D; Rouleau JL
Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
[TBL] [Abstract][Full Text] [Related]
19. Hormonal changes in patients with severe chronic congestive heart failure treated by ultrafiltration.
Forslund T; Riddervold F; Fauchald P; Torvik D; Fyhrquist F; Simonsen S
Nephrol Dial Transplant; 1992; 7(4):306-10. PubMed ID: 1317520
[TBL] [Abstract][Full Text] [Related]
20. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Tsutamoto T; Kinoshita M; Nakae I; Maeda Y; Wada A; Yabe T; Horie H
Am Heart J; 1994 Apr; 127(4 Pt 1):866-73. PubMed ID: 8154425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
